This is Why Shares of Moderna Just Fell 12%

Just this morning, Moderna (MRNA) was downgraded by JP Morgan on valuation concerns. In fact, analyst Cory Kasimov said that while he is bullish on the stock, MRNA can no longer support the stock’s valuation. On that news, MRNA fell $10.  However, the pullback may not last long thanks to strong COVID-19 study results.  Remember, … Continue reading “This is Why Shares of Moderna Just Fell 12%”